Watertown, MA, United States of America

Elyse M J Bourque

This inventor holds 1 USPTO granted patent. Top assignees: Genzyme Corporation, Harvard College, Massachusetts Institute of Technology. Active years: 2015.


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elyse M J Bourque: Innovator in Malaria Treatment

Introduction

Elyse M J Bourque is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of malaria. His innovative work has led to the development of a unique patent that addresses this critical health issue.

Latest Patents

Elyse M J Bourque holds 1 patent for his invention titled "2-aminoindole compounds and methods for the treatment of malaria." This patent relates to methods of treating a subject with malaria by administering a 2-aminoindole compound represented by a specific formula. The values and preferred values of the variables in this structural formula are defined within the patent documentation.

Career Highlights

Throughout his career, Elyse has worked with prominent organizations, including Genzyme Corporation and the Massachusetts Institute of Technology. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Elyse has collaborated with notable colleagues, including Sameer Urgaonkar and Ralph Mazitschek. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical research.

Conclusion

Elyse M J Bourque's contributions to malaria treatment through his innovative patent demonstrate his commitment to improving health outcomes. His work exemplifies the impact of dedicated inventors in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…